Lexaria’s DehydraTECH technology shown to improve rapidity of deliver and quantity of nicotine delivered in first-generation animal studies

Lexaria Focusing on Four Core Business Segments:
• Heart disease including hypertension
• Reduced-risk non combusted nicotine
• Improved antiviral drug delivery
• CBD from hemp

Learn More